JESSICA FOOTE: Open Payments
NPI 1154066264 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 51 payments from 14 companies in 2025. Trend: 2023 $122 · 2024 $815 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $421 |
| Novo Nordisk Inc | 9 | $237 |
| PFIZER INC. | 5 | $90 |
| Lilly USA, LLC | 2 | $48 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Exact Sciences Corporation | 2 | $33 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| Amgen Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $21 |
Products named: Wegovy, QULIPTA, UBRELVY, VRAYLAR, NURTEC ODT, Ozempic, Jornay PM, Cologuard Collection Kit.
Industry payments across MO — which companies pay providers there.
